Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Catalyst Pharmaceuticals (CPRX) Shares Repurchased: 2015-2022

Historic Shares Repurchased for Catalyst Pharmaceuticals (CPRX) over the last 4 years, with Jun 2022 value amounting to $4.4 million.

  • Catalyst Pharmaceuticals' Shares Repurchased rose 18.92% to $4.4 million in Q2 2022 from the same period last year, while for Jun 2022 it was $15.2 million, marking a year-over-year increase of 277.02%. This contributed to the annual value of $6.9 million for FY2022, which is 42.92% down from last year.
  • According to the latest figures from Q2 2022, Catalyst Pharmaceuticals' Shares Repurchased is $4.4 million, which was up 69.23% from $2.6 million recorded in Q1 2022.
  • In the past 5 years, Catalyst Pharmaceuticals' Shares Repurchased ranged from a high of $5.1 million in Q3 2021 and a low of $300,000 during Q1 2021.
  • In the last 2 years, Catalyst Pharmaceuticals' Shares Repurchased had a median value of $3.4 million in 2021 and averaged $3.2 million.
  • Data for Catalyst Pharmaceuticals' Shares Repurchased shows a peak YoY skyrocketed of 766.67% (in 2022) over the last 5 years.
  • Quarterly analysis of 2 years shows Catalyst Pharmaceuticals' Shares Repurchased stood at $3.1 million in 2021, then grew by 18.92% to $4.4 million in 2022.
  • Its Shares Repurchased was $4.4 million in Q2 2022, compared to $2.6 million in Q1 2022 and $3.1 million in Q4 2021.